Welcome to Antibody-drug Conjugates 101: Overview , your gateway to exploring the fascinating world of ADCs in biopharma. Focusing on the key facets of Antibody-drug Conjugate development and manufacture. This course provides a thorough insight into ADC processing for all audiences regardless of scientific background.
Course Highlights:
Biologics vs. Small Molecules: Begin by understanding the distinction between Biologics and Small Molecules, and how ADCs bridge the gap.
ADCs: Dive deep into Antibody-drug Conjugates (ADCs), a promising class of biopharmaceuticals, and explore their potential in targeted therapies.
Define Clinical Trial Phases: Navigate the clinical development journey by defining the phases and stages crucial for bringing ADCs to market.
Upstream Process Overview: Explore the intricacies of the upstream processes involved in ADC production, from cell line development to antibody expression.
Downstream Process Overview: Gain insights into the downstream processes that refine and purify ADCs, ensuring product safety and efficacy.
Join us at the National Horizons Centre (NHC) as we guide you through the captivating journey of Antibody-drug Conjugates. Whether you're new to the field or a recent graduate entering biopharma, this course equips you with the knowledge and skills needed to excel.
